![Rekha Hemrajani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rekha Hemrajani
Directeur/Membre du Conseil chez
BIOAGE LABS, INC.
Fortune : 199 650 $ au 31/05/2026
Profil
Rekha Hemrajani is the founder of Ravinia Consulting, Inc. Current jobs include Independent Non-Executive Director at MaxCyte, Inc. since 2021, Independent Director at BioAge Labs, Inc. since 2021, Director at ALX Oncology, Inc. since 2020, Director & Partner at Hemmo Pharmaceuticals Pvt Ltd., Non-Executive Independent Director at ALX Oncology Holdings, Inc. since 2020, Director & Partner at Hemmo Pharma LLP, and Independent Director at LB Pharmaceuticals, Inc. starting 2025.
Former jobs include President, Chief Executive Officer & Director at Aravive, Inc. in 2020, Chief Executive Officer & Director at Jiya Acquisition Corp.
from 2020 to 2022, Independent Director at Adverum Biotechnologies, Inc. from 2019 to 2021, Vice President at Lehman Brothers, Inc., VP & Head-Licensing, Mergers & Acquisitions at Onyx Pharmaceuticals, Inc. from 2012 to 2013, Vice President-Business Development at Exelixis, Inc. from 2003 to 2011, CFO, SVP-Business & Financial Operations at Sagimet Biosciences, Inc. from 2015 to 2016, Chief Operating Officer at Rapt Therapeutics, Inc. from 2016 to 2019, and Chief Operating & Financial Officer at Arcus Biosciences, Inc. in 2019.
Education includes undergraduate studies at the University of Michigan and an MBA from Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MAXCYTE, INC. 0,07 % | 17/06/2026 | 70 314 ( 0,07 % ) | 85 080 $ | 31/05/2026 |
| 31/03/2026 | 33 000 ( 0,02 % ) | 62 700 $ | 31/05/2026 | |
BIOAGE LABS, INC. 0,01 % | 10/06/2026 | 3 000 ( 0,01 % ) | 51 870 $ | 31/05/2026 |
Postes actifs de Rekha Hemrajani
| Sociétés | Poste | Début |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Directeur/Membre du Conseil | 01/04/2020 |
| MAXCYTE, INC. | Directeur/Membre du Conseil | 15/06/2021 |
| BIOAGE LABS, INC. | Directeur/Membre du Conseil | 19/08/2021 |
| LB PHARMACEUTICALS INC | Directeur/Membre du Conseil | 10/09/2025 |
ALX Oncology, Inc.
 ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company which develops therapies for cancers | Directeur/Membre du Conseil | 04/05/2020 |
Hemmo Pharma LLP | Directeur/Membre du Conseil | - |
Hemmo Pharmaceuticals Pvt Ltd.
 Hemmo Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures peptide APIs | Directeur/Membre du Conseil | - |
Anciens postes connus de Rekha Hemrajani
| Sociétés | Poste | Fin |
|---|---|---|
| JIYA ACQUISITION CORP. | Directeur Général | 01/11/2022 |
| ADVERUM BIOTECHNOLOGIES, INC. | Directeur/Membre du Conseil | 12/05/2021 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Rekha Hemrajani
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
MaxCyte, Inc.
 MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sagimet Biosciences, Inc.
 Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rapt Therapeutics, Inc.
 Rapt Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oral small molecule therapies for patients | Health Technology |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
LB Pharmaceuticals, Inc.
 LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and neuropsychiatric diseases | Health Technology |
BioAge Labs, Inc.
 BioAge Labs, Inc. BiotechnologyHealth Technology Develops therapies obesity for metabolic diseases | Health Technology |
Aravive, Inc.
 Aravive, Inc. BiotechnologyHealth Technology Develops therapies for solid tumors and hematologic malignancies | Health Technology |
ALX Oncology, Inc.
ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company which develops therapies for cancers | Health Technology |
Hemmo Pharmaceuticals Pvt Ltd.
Hemmo Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures peptide APIs | Health Technology |
ALX Oncology Holdings, Inc.
 ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
Jiya Acquisition Corp.
 Jiya Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Hemmo Pharma LLP | |
Ravinia Consulting, Inc.
 Ravinia Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Ravinia Consulting, Inc. is a company located in the US. | Commercial Services |
Choisissez Zonebourse 
